PRKAA1 and fatty liver disease: Critically, it has been reported that phosphorylation of AMPKα at residue Thr172 (p-AMPK) is decreased in HCV-infected cells, indicating that AMPK participates in the pathogenesis of HCV-associated hepatic steatosis [18, 35].